Low-Dose Naltrexone (LDN) and Pharmacy Care
LDN Support

Low-Dose Naltrexone (LDN) and Pharmacy Care 

Practical support for patients discussing off-label LDN with a prescriber: medication review, opioid interaction screening, titration labels, refill planning, and compounded non-commercial strengths when prescribed.

Call (204) 233-3469

Understanding Low-Dose Naltrexone

Naltrexone is a prescription medication sold commercially in 50 mg tablets for substance-use treatment. Low-dose naltrexone, often shortened to LDN, refers to much smaller prescribed doses that are used off-label in some chronic pain, inflammatory, autoimmune, and fatigue-related care plans.

LDN is not a first-line treatment for every condition, and the research varies by diagnosis. It is a conversation to have with a physician, nurse practitioner, pain clinic, rheumatology, neurology, gastroenterology, or another prescriber who knows the full medical history.

The pharmacy role is practical: we review the prescription, screen for medication conflicts, prepare the non-commercial strength when prescribed, explain the label, and help patients organize titration, refills, storage, and follow-up questions.

Understanding Low-Dose Naltrexone
PHARMACY SUPPORT

How the Pharmacy Can Help

LDN is a prescription conversation first. The pharmacy supports the medication-use details once a prescriber is involved.

Medication Review

We review opioid medications, other prescriptions, non-prescription products, and allergy or ingredient concerns before preparation.

Titration Support

If the prescription changes strengths over time, we help clarify the label, timing, quantity, and refill dates.

Dosage Form Planning

Capsules and oral liquid may be considered depending on the prescription, dose, and patient-specific needs.

Follow-Up Questions

We help identify what should be tracked and which questions should go back to the prescriber.

REGULAR PHARMACY CARE

Medication Review Comes First

Before compounding, the most important pharmacy step is checking the medication history and clarifying the prescription.

LDN questions usually involve more than the capsule itself. Patients often need help understanding whether the prescription has a titration schedule, whether the timing should change, how to plan refills, and which medication interactions need prescriber review.

Our pharmacists can help with:

  • Medication review. Naltrexone cannot be used with opioid medications unless the prescriber has specifically directed a transition plan.
  • Label clarity. Some prescriptions start at a lower dose and increase slowly. We can help make sure each step is clear.
  • Refill planning. Changing strengths during titration can affect timing, quantity, and when the next prescription is needed.
  • Side-effect questions. Sleep changes, vivid dreams, headache, nausea, or mood changes should be discussed if they persist or concern the patient.
  • Prescriber communication. If the prescription details are unclear, or if opioid use appears in the medication history, we contact the prescriber before preparing.

Patients should tell the pharmacy about prescription medications, non-prescription products, supplements, liver disease history, opioid use, recent opioid use, and upcoming surgery or dental procedures.

Where Compounding Fits

LDN strengths used in off-label care are much smaller than the commercially available 50 mg naltrexone tablet. Splitting a 50 mg tablet into very small doses is not a practical way to prepare a consistent prescribed strength.

Compounding may be used when a prescriber writes for:

  • Non-commercial strengths. Capsules or liquid can be prepared at the strength selected by the prescriber.
  • Titration steps. The prescription may change over time as the prescriber adjusts the dose.
  • Capsules or oral liquid. The dosage form can be selected based on the prescription and patient needs.
  • Inactive ingredient review. A preparation can be reviewed for dye, lactose, gluten, gelatin, or other ingredient concerns when relevant.
  • Refill quantities. Quantity and beyond-use date should match the prescriber's plan and the preparation being made.

Compounded LDN requires a prescription for an individual patient. The prescriber decides the diagnosis, dose, timing, titration, monitoring, and whether LDN belongs in the care plan.

Where Compounding Fits
COMPOUNDING OPTIONS

LDN Dosage Forms and Details

The prescriber chooses the dose and directions. We prepare the prescription and help with practical medication-use questions.

Capsules

Capsules are a common dosage form for prescribed LDN strengths and titration plans.

Oral Liquid

Oral liquid may be considered when capsules are not practical or when the prescription requires small adjustments.

Step-Up Schedules

If the prescription includes titration, labels and refill timing can be organized around each strength.

Excipient Review

Base, capsule, filler, and dye concerns can be reviewed before preparation.

DISCUSSION TOPICS

Common LDN Conversation Points

These topics often come up when patients ask about LDN. They should be reviewed in the context of the patient's diagnosis and medication history.

Chronic Pain and Fibromyalgia

LDN is discussed in some chronic pain care plans. The evidence and expectations should be reviewed with the prescriber.

Fatigue and Function Tracking

Some patients track fatigue, sleep, activity, and flares during a trial so follow-up is more specific.

Autoimmune Discussions

LDN is sometimes discussed in autoimmune or inflammatory conditions, but appropriateness depends on diagnosis and medical history.

Medication Timing

Timing is prescriber-specific. Sleep changes or vivid dreams are common reasons patients ask whether timing should be reviewed.

Ingredient Concerns

The prescription can be reviewed for inactive ingredients such as dye, lactose, gluten, gelatin, or capsule type.

Prescriber Monitoring

Patients should ask what follow-up, symptom tracking, or bloodwork matters for their situation.

EVIDENCE AND EXPECTATIONS

Set Expectations With Your Prescriber

LDN research is evolving and varies by condition. A useful trial needs a clear reason, monitoring plan, and follow-up date.

LDN has been studied most often in fibromyalgia and chronic pain, with smaller studies and observational reports in other conditions. Some studies have reported symptom improvements, while other research has found uncertain or limited benefit. This is why it should be presented as an off-label option to discuss, not as a guaranteed result.

Helpful questions for the prescriber include:

  • What diagnosis or symptom target is LDN being considered for?
  • What evidence applies to this condition and this patient's medical history?
  • What dose and titration schedule should be used?
  • How long should the trial continue before follow-up?
  • What changes should be tracked: pain, fatigue, sleep, bowel symptoms, flares, function, or medication use?
  • What symptoms or side effects should trigger a call?

The pharmacy can explain how the prescription will be prepared and used, but the clinical decision about whether to try LDN belongs with the prescriber.

BEFORE YOUR APPOINTMENT

What to Bring Up Before Starting LDN

LDN is easier to assess when the prescriber can see the full medication list, prior treatments, and what the patient hopes to track.

Before asking about LDN, gather the information that helps the prescriber decide whether it is reasonable to discuss.

  • Current diagnosis, symptom pattern, and what has already been tried
  • Prescription medications, non-prescription pain relievers, supplements, cannabis products, and topical products
  • Any opioid medication, recent opioid use, opioid-use disorder treatment, or planned surgery or dental procedure
  • Liver disease history or recent bloodwork, if relevant
  • Pregnancy, breastfeeding, or fertility plans, if relevant
  • Sleep history, mood history, and any previous medication reactions
  • What you would track during a trial: pain scores, fatigue, function, sleep, flares, or other symptoms

Bring your medication list to the pharmacy before the prescription is prepared, especially if opioids or opioid-containing products may be involved.

Taché Pharmacy refill app preview
Ongoing Care

Refills and pharmacy follow-up from your phone

  • Request refills for ongoing prescriptions
  • Set medication reminders
  • Follow pickup or delivery updates
  • Send pharmacy questions in one place
COMMON QUESTIONS

Have Questions?
Low-Dose Naltrexone Questions

Yes. Naltrexone is a prescription medication in Canada, including when prescribed at low doses. The prescriber decides whether it belongs in the care plan and writes the strength, quantity, directions, and follow-up plan.
Tell your prescriber and pharmacist about any opioid medication, opioid-use disorder treatment, recent opioid use, or planned surgery. Naltrexone blocks opioid receptors and can create serious problems if opioids are involved without a prescriber-directed plan.
LDN prescriptions often use low milligram strengths and may start low with gradual changes. The specific strength and titration schedule must come from the prescriber.
That depends on the condition, dose, tracking plan, and prescriber expectations. Ask before starting what should be monitored and when follow-up should happen.
Patients often ask about vivid dreams, sleep changes, headache, nausea, mood changes, and what symptoms should trigger a call. Discuss persistent or concerning symptoms with the prescriber or pharmacist.
Often, depending on the prescription and dosage form. Tell the pharmacy about dye, lactose, gluten, gelatin, or other ingredient concerns before the preparation is made.

Have questions about an LDN prescription?

Call once a prescription is written, or before filling if you need help reviewing medication conflicts, opioid concerns, inactive ingredients, titration labels, or refill timing.